105 related articles for article (PubMed ID: 1883913)
1. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
[TBL] [Abstract][Full Text] [Related]
3. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
4. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
5. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
8. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
[TBL] [Abstract][Full Text] [Related]
9. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats.
Carson WE; Jakowatz JG; Yamamoto R; Fitzgerald T; Gupta S; Vayuvegula B; Lucci JA; Beckman MT; Dulkanchainun S; Granger GA
J Immunother (1991); 1991 Apr; 10(2):131-40. PubMed ID: 2043593
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta.
Zahn G; Greischel A
Arzneimittelforschung; 1989 Sep; 39(9):1180-2. PubMed ID: 2590273
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
14. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
15. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
Siesjö P; Visse E; Sjögren HO
J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):334-45. PubMed ID: 8941873
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
17. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
[TBL] [Abstract][Full Text] [Related]
18. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.
Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y
Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
[TBL] [Abstract][Full Text] [Related]
20. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
Fletcher WH; Shiu WW; Ishida TA; Haviland DL; Ware CF
J Immunol; 1987 Aug; 139(3):956-62. PubMed ID: 3110292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]